Patent directory · USPTO A61K / A61P
Patents matching “Allogene Therapeutics, Inc.”
16 pharma patents match "Allogene Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 16 pharmaceutical patents matching "Allogene Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12404315
Protease-activating CD45-gate CAR
granted -
US 12365873
Methods for transducing immune cells
granted -
US 12295362
Formulations and processes for CAR T cell drug products
granted -
US 12221462
Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells
granted -
US 12215347
Chimeric antigen receptors with enhanced signaling and activities and uses thereof
granted -
US 12163153
Methods of manufacturing allogeneic CAR T cells
granted -
US 12163169
Inducible chimeric cytokine receptors
granted -
US 12104188
Modified caspase-9 polypeptides and methods of use thereof
granted -
US 12043655
Constitutively active chimeric cytokine receptors
granted -
US 12036243
BCMA CAR-T cells with enhanced activities
granted -
US 11896617
Polynucleotides encoding rituximab-resistant chimeric antigen receptors
granted -
US 11786553
Chimeric cytokine receptors bearing a PD-1 ectodomain
granted -
US 11732041
Antibodies against 4G7-derived chimeric antigen receptors
granted -
US 11673953
DLL3 targeting chimeric antigen receptors and binding agents
granted -
US 11326156
Modified caspase-9 polypeptides and methods of use thereof
granted -
US 11072644
Inhibitory chimeric antigen receptors
granted